News

Article

AJMC® in the Press, April 26, 2024

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article in The Dallas Morning News referenced a study to be published in the June 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients,” found that high-risk patients had a significant reduction in hospitalizations with increased visits to their primary care physician.

An article from Healthcare Finance referenced an article to be published in the May 2024 issue of AJMC. The study, “Accountable Care Organization Initiatives to Improve the Cost and Outcomes of Specialty Care,” discussed challenges in engaging specialists in accountable care organizations.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Jorge J. Nieva, MD, Keck School of Medicine
Eric Lander, MD
Gordon Crofoot, MD, PA
5 experts are featured in this series
4 experts in this video
1 expert is featured in this series.
5 experts are featured in this series
Related Content
Affordable Care Act | Image credit: Yauhen - stock.adobe.com
June 20th 2025

Many Still Pay for Colonoscopy Prep Despite ACA Coverage Mandate

Pearl Steinzor
Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and patient-preferred prep options, study finds.
Logo for Managed Care Cast
June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA
Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Clinical trial researchers interact with data | Image Credit: elenabsl - stock.adobe.com .jpeg
June 20th 2025

Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria

Giuliana Grossi
Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney disease (CKD), highlighting its dual-action benefits.
Managed Care Cast
June 17th 2025

Managed Care Cast News Roundup: June 17, 2025

Giuliana Grossi
A quick roundup episode of major news and health policy developments from The American Journal of Managed Care.
New York street with smoke | Image credit : Jay De Winne – stock.adobe.com
June 20th 2025

Air Pollution, Obesity Linked to Significant Liver Fibrosis in Patients With MASH

Hayden E. Klein
There was no association observed between lower income and increased fibrosis among New York City residents with metabolic dysfunction-associated steatohepatitis (MASH).
Colleen Kelley, MD, MPH
June 20th 2025

Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH

Julia Bonavitacola Colleen Kelley, MD, MPH
The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo